TrialBreast cancer research and treatment2024

Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY.

Judith Balmaña et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.